ArticleFrontiers in cardiovascular medicine2021

Metabolic Impairment in Coronary Artery Disease: Elevated Serum Acylcarnitines Under the Spotlights.

Joséphine Gander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.